File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: 2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation

Title2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation
Authors
KeywordsAnticoagulation
Atrial fibrillation
Non‐vitamin K antagonist oral anticoagulants
Vitamin K
antagonist Stroke
Issue Date2017
PublisherElsevier Japan KK. The Journal's web site is located at http://www.journalofarrhythmia.com
Citation
Journal of Arrhythmia, 2017, v. 33 n. 4, p. 345-367 How to Cite?
AbstractAtrial fibrillation (AF) is the most common sustained arrhythmia, causing a 2‐fold increase in mortality and a 5‐fold increase in stroke. The Asian population is rapidly aging, and in 2050, the estimated population with AF will reach 72 million, of whom 2.9 million may suffer from AF‐associated stroke. Therefore, stroke prevention in AF is an urgent issue in Asia. Many innovative advances in the management of AF‐associated stroke have emerged recently, including new scoring systems for predicting stroke and bleeding risks, the development of non‐vitamin K antagonist oral anticoagulants (NOACs), knowledge of their special benefits in Asians, and new techniques. The Asia Pacific Heart Rhythm Society (APHRS) aimed to update the available information, and appointed the Practice Guideline sub‐committee to write a consensus statement regarding stroke prevention in AF. The Practice Guidelines sub‐committee members comprehensively reviewed updated information on stroke prevention in AF, emphasizing data on NOACs from the Asia Pacific region, and summarized them in this 2017 Consensus of the Asia Pacific Heart Rhythm Society on Stroke Prevention in AF. This consensus includes details of the updated recommendations, along with their background and rationale, focusing on data from the Asia Pacific region. We hope this consensus can be a practical tool for cardiologists, neurologists, geriatricians, and general practitioners in this region. We fully realize that there are gaps, unaddressed questions, and many areas of uncertainty and debate in the current knowledge of AF, and the physician׳s decision remains the most important factor in the management of AF.
Persistent Identifierhttp://hdl.handle.net/10722/275126
ISSN
2015 SCImago Journal Rankings: 0.205
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorChiang, C-E-
dc.contributor.authorOkumura, KO-
dc.contributor.authorZhang, S-
dc.contributor.authorChao, T-F-
dc.contributor.authorSiu, C-W-
dc.contributor.authorLim, TW-
dc.contributor.authorSaxena, A-
dc.contributor.authorTakahashi, Y-
dc.contributor.authorTeo, WS-
dc.date.accessioned2019-09-10T02:36:00Z-
dc.date.available2019-09-10T02:36:00Z-
dc.date.issued2017-
dc.identifier.citationJournal of Arrhythmia, 2017, v. 33 n. 4, p. 345-367-
dc.identifier.issn1880-4276-
dc.identifier.urihttp://hdl.handle.net/10722/275126-
dc.description.abstractAtrial fibrillation (AF) is the most common sustained arrhythmia, causing a 2‐fold increase in mortality and a 5‐fold increase in stroke. The Asian population is rapidly aging, and in 2050, the estimated population with AF will reach 72 million, of whom 2.9 million may suffer from AF‐associated stroke. Therefore, stroke prevention in AF is an urgent issue in Asia. Many innovative advances in the management of AF‐associated stroke have emerged recently, including new scoring systems for predicting stroke and bleeding risks, the development of non‐vitamin K antagonist oral anticoagulants (NOACs), knowledge of their special benefits in Asians, and new techniques. The Asia Pacific Heart Rhythm Society (APHRS) aimed to update the available information, and appointed the Practice Guideline sub‐committee to write a consensus statement regarding stroke prevention in AF. The Practice Guidelines sub‐committee members comprehensively reviewed updated information on stroke prevention in AF, emphasizing data on NOACs from the Asia Pacific region, and summarized them in this 2017 Consensus of the Asia Pacific Heart Rhythm Society on Stroke Prevention in AF. This consensus includes details of the updated recommendations, along with their background and rationale, focusing on data from the Asia Pacific region. We hope this consensus can be a practical tool for cardiologists, neurologists, geriatricians, and general practitioners in this region. We fully realize that there are gaps, unaddressed questions, and many areas of uncertainty and debate in the current knowledge of AF, and the physician׳s decision remains the most important factor in the management of AF.-
dc.languageeng-
dc.publisherElsevier Japan KK. The Journal's web site is located at http://www.journalofarrhythmia.com-
dc.relation.ispartofJournal of Arrhythmia-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectAnticoagulation-
dc.subjectAtrial fibrillation-
dc.subjectNon‐vitamin K antagonist oral anticoagulants-
dc.subjectVitamin K-
dc.subjectantagonist Stroke-
dc.title2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation-
dc.typeArticle-
dc.identifier.emailSiu, DCW: cwdsiu@hkucc.hku.hk-
dc.identifier.authoritySiu, DCW=rp00534-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1016/j.joa.2017.05.004-
dc.identifier.scopuseid_2-s2.0-85021723126-
dc.identifier.hkuros304687-
dc.identifier.volume33-
dc.identifier.issue4-
dc.identifier.spage345-
dc.identifier.epage367-
dc.identifier.isiWOS:000407853500019-
dc.publisher.placeJapan-
dc.identifier.issnl1880-4276-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats